Living with cancer has forced me to know my limitations, even though it conflicts with my "can-do" personality.
On Monday, April 21, the Food and Drug Administration approved Cyramza (ramucirumab) to treat patients with advanced stomach cancer or cancer where the esophagus meets the stomach (gastroesophageal junction adenocarcinoma).
This week the American Society of Clinical Oncology (ASCO) issued three evidence-based guidelines for cancer survivorship.
Whether it is on the national stage or a local support group, advocacy after caregiving can be a rewarding experience.
A new law hopes to speed drug development for therapies in the age of biomarker-driven treatment.
Focusing on screening and genetic clues, progress in lung cancer shifts forward.